Extract from the Register of European Patents

EP About this file: EP1795609

EP1795609 - Method for the diagnosis and treatment of cardiovascular diseases [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.12.2008
Database last updated on 26.03.2026
Most recent event   Tooltip05.12.2008Application deemed to be withdrawnpublished on 07.01.2009  [2009/02]
Applicant(s)For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
[N/P]
Former [2007/30]For all designated states
sanofi-aventis
174, Avenue de France
75013 Paris / FR
Former [2007/29]For all designated states
Sanofi-Aventis
174 avenue de France
75635 Paris / FR
Former [2007/24]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / Kozian, Detlef, Dr.
Altenhainer Strasse 19
65779 Kelkeim / DE
02 / Herrmann, Matthias, Dr.
Zum Morgengraben 30
65835 Liederbach / DE
03 / Leeuw, Thomas, Dr., c/o Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65926 Frankfurt / DE
04 / Renner, Wilfried
Mariatrosterstrasse 118a
8043 Graz / AT
05 / Maerz, Winfried
Seligenstädterstrasse 82
63073 Offenbach / DE
 [2007/24]
Representative(s)Bankmann, Michael, et al
Sanofi-Aventis Deutschland GmbH
Global Intellectual Property Department
Industriepark Höchst
Gebäude K 703
65926 Frankfurt am Main / DE
[N/P]
Former [2007/29]Bankmann, Michael, et al
Sanofi-Aventis Deutschland GmbH Patent- und Lizenzabteilung Industriepark Höchst Gebäude K 801
65926 Frankfurt am Main / DE
Application number, filing date05026569.306.12.2005
[2007/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1795609
Date:13.06.2007
Language:EN
[2007/24]
Search report(s)(Supplementary) European search report - dispatched on:EP13.04.2006
ClassificationIPC:C12Q1/68
[2007/24]
CPC:
C12Q1/6883 (EP,KR,US); A61P7/02 (EP); A61P9/08 (EP);
A61P9/10 (EP); A61P9/12 (EP); G01N33/53 (KR);
G01N33/573 (EP,US); C12Q2600/106 (EP,KR,US); C12Q2600/136 (EP,KR,US);
C12Q2600/156 (EP,KR,US); G01N2333/91215 (EP,KR,US); G01N2800/32 (EP,KR,US);
G01N2800/52 (EP,KR,US) (-)
Designated contracting statesDE [2008/08]
Former [2007/24]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verfahren zur Diagnose und Behandlung von kardiovaskulären Krankheiten[2007/24]
English:Method for the diagnosis and treatment of cardiovascular diseases[2007/24]
French:Méthode de diagnostique et de traitement des maladies cardiovasculaires[2007/24]
Examination procedure13.12.2007Examination requested  [2008/04]
14.12.2007Loss of particular rights, legal effect: designated state(s)
04.02.2008Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
14.02.2008Despatch of a communication from the examining division (Time limit: M04)
25.06.2008Application deemed to be withdrawn, date of legal effect  [2009/02]
14.08.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/02]
Fees paidRenewal fee
02.01.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] WO0188188  (UNIV SCHOOL NIHON JURIDIC PER et al.)
 [A] US2003211525  (WALKER MICHAEL G et al.)
 [A]   BRAUN F ET AL: "Differential gene expression during intestinal ischemia-reperfusion injury.", TRANSPLANTATION PROCEEDINGS. SEP 2002, vol. 34, no. 6, September 2002 (2002-09-01), pages 2301 - 2302, XP002372425, ISSN: 0041-1345

DOI:   http://dx.doi.org/10.1016/S0041-1345(02)03244-X
 [A]   DATABASE DBSNP [online] ncbi; 29 August 2001 (2001-08-29), "refSNP ID: rs2241909", XP002372732, retrieved from NCBI Database accession no. RS2241909
 [A]   DATABASE DBSNP [online] ncbi; 16 October 2000 (2000-10-16), "refSNP ID: rs1059476", XP002372733, retrieved from NCBI Database accession no. RS1059476
 [A]   OTA TAKAHIDE ET AL: "Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability.", CANCER RESEARCH. 15 SEP 2002, vol. 62, no. 18, 15 September 2002 (2002-09-15), pages 5168 - 5177, XP002372426, ISSN: 0008-5472
by applicantUS5744305
 EP0944398
 EP0916336
 EP0889723
 EP0852493
   VANKAYALAPATI, H., MOLECULAR CANCER THERAPEUTICS, vol. 2, 2003, pages 283 - 294
   SHINDO, M., MOLECULAR CANCER THERAPEUTICS, vol. 244, 1998, pages 285 - 292
   DESCAMPS; PRIGENT, SCI. STKE, vol. 173, 2001, pages 1
   SHI M. M., AM J PHARMACOGENOMICS., vol. 2, no. 3, 2002, pages 197 - 205
   KOZIAN; KIRSCHBAUM, TRENDS BIOTECHNOL., vol. 17, no. 2, 1999, pages 73 - 8
   SCHOBEL, U., BIOCONJUGATE CHEM., vol. 10, 1999, pages 1107 - 1114
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.